Boswellia Serrata Extract in Acute Diarrhea

Not Applicable

Completed

• Conditions: Acute Diarrhea; Boswellia Serrata

• Registration Number: NCT05345028
• Lead Sponsor: Azienda di Servizi alla Persona di Pavia

Brief Summary

Acute diarrhea is a frequent problem worldwide, mostly due to gastrointestinal infections or food poisoning. Boswellia serrata could be active in the treatment of acute diarrhea due to its an-ti-inflammatory, antispasmodic and antimicrobial activity.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-03
• Primary Completion: 2021-05-24
• Study Completion: 2021-09-07
• Status Verified: 2022-04
• Study First Submitted: 2022-04-12
• Study First Submitted QC: 2022-04-19
• Last Update Submitted: 2022-04-19
• Study First Posted: 2022-04-25
• Last Update Posted: 2022-04-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 49

Inclusion Criteria

• presence of acute diarrhea of mild to moderate severity

Exclusion Criteria

• patients with long term diarrhea
• iatrogenic diarrhea
• symptoms of functional gut disease or severe inter-current diseases
• severe diarrhea and dehydration requiring hospitalization and intravenous treatment
• subjects with high temperature (> 38.5° C)
• subjects treated by other anti-diarrheal and antibiotic drugs in the last 24 hours
• severely malnourished subjects
• pregnant women

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Stoppage of diarrhea	From baseline to 5 days	the occurrence of the first formed stool or a period of 12 hours without any liquid or soft stools

Secondary Outcome Measures

Name	Time	Method
Self-assessed symptoms	After 5 days	percentage of subjects without diarrhea within 5 days of treatment

Trial Locations

Locations (1)

Azienda di Servizi alla Persona; 🇮🇹 Pavia, Italy